SEP 13, 2021 3:00 AM PDT

Fat Loss can Predict Gastric Cancer Survival

WRITTEN BY: Katie Kokolus

Cancer cachexia is a metabolic disorder in cancer patients experiencing uncontrolled weight loss.  While cancer cachexia occurs in all cancer types, it is most common in pancreatic, gastro-oesophageal, head and neck, lung, and colorectal cancers. 

There is a very high rate of cancer cachexia for patients nearing the end of life, but it also arises in smaller frequencies in patients with curable cancers.  While nutritional interventions are ineffective at treating cachexia in cancer patients, successful treatment of the underlying cancer can reverse the symptoms. 

Cancer cachexia correlates to poor overall survival, and this subset of patients are less responsive to cancer therapies, including chemotherapy

One of the major drivers of cancer cachexia is adipose tissue loss.  There are two major types of adipose tissues, white and brown.  White adipose tissue, fatty tissue responsible for storing energy within the body for use by other organs, contains subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT). 

SAT is located throughout the body beneath the skin, and VAT is concentrated around the abdomen.  While VAT is linked to other metabolic syndromes, including insulin resistance and diabetes, the contribution of SAT and VAT to the development of cancer cachexia is not well understood.

A recent study published in Clinical Nutrition investigated the contributions of SAT and VAT in gastric cancer patients with cachexia.  The study enrolled over 1600 gastric cancer patients, including 411 with cachexia and 1216 without cachexia.  Patients received a CT scan that the research team used to measure SAT and VAT around the L3 vertebra.  Calculations made from these scans determined the areas of SAT and VAT following normalization for patient height. 

The researchers found that SAT was significantly lower in cancer patients with cachexia than non-cachexia patients.  Further, among the cachexia patients, low SAT correlated with poor survival.

The study found no difference in VAT between the cachexia and non-cachexia patients, nor was there any effect of VAT on survival. 

This study confirms that adipose tissues loss is a key feature of cachexia among gastric cancer patients.  Additionally, the study demonstrates that SAT, but not VAT, is a driving factor of cachexia in this cohort of patients.  The authors propose the use of SAT as a prognostic factor for cachexic gastric cancer patients. 

 

Sources: Cancer cachexiacommonchemotherapyadipose tissueClinical Nutrition

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JUL 28, 2022
Clinical & Molecular DX
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
JUL 28, 2022
Pancreatic Cancer is Difficult to Detect in its Curable Early Stages: AI Could Soon Change This
Pancreatic cancer typically does not cause symptoms until after it has spread to other organs. This makes it very diffic ...
SEP 15, 2022
Immunology
How a Cancer-Causing Virus Evades Human Immunity
SEP 15, 2022
How a Cancer-Causing Virus Evades Human Immunity
While our immune system is usually able to identify and destroy pathogenic invaders like bacteria and viruses, those mic ...
SEP 13, 2022
Health & Medicine
Mesothelioma: What Is it and What can Patients Diagnosed With it Do to Improve Quality of Life
SEP 13, 2022
Mesothelioma: What Is it and What can Patients Diagnosed With it Do to Improve Quality of Life
A 2022 Centers for Diseases Control and Prevention (CDC) report showed only 2,385 mesothelioma cases in the United State ...
SEP 28, 2022
Drug Discovery & Development
Impact of In Vivo Controls on Therapeutic Drug Development
SEP 28, 2022
Impact of In Vivo Controls on Therapeutic Drug Development
The significance of antibody based in vivo studies   For both research and therapeutic purposes, antibodies ca ...
OCT 04, 2022
Cardiology
Brisk Walking Reduces Risk of Heart Disease, Cancer, and More
OCT 04, 2022
Brisk Walking Reduces Risk of Heart Disease, Cancer, and More
Getting your steps in at a brisker pace reduces the risk of cancer, heart disease, dementia, and premature death.
NOV 11, 2022
Cancer
Veterans and Burn Pit Exposure
NOV 11, 2022
Veterans and Burn Pit Exposure
Today we recognize the Veterans Day holiday in the United States.  Each year, on November 11, Americans commemorate ...
Loading Comments...